Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 8366

BillFederalHouseIn Committee
PEARL Act
About This Bill
Committee
Latest Action · April 20, 2026
Referred to the House Committee on Energy and Commerce.
Congress
119th (2025–2027)
Introduced
April 20, 2026
Cosponsors (0)
None
View PDF ↗

Summary

Highlight any text to annotate
The PEARL Act would allow pharmacists to refuse to dispense or sell the abortion drugs mifepristone and misoprostol if doing so conflicts with their sincerely held religious beliefs. The bill prohibits employers, licensing boards, and the federal government from punishing pharmacists who make this choice, including through license revocation or withdrawal of federal funding. The legislation applies to all pharmacists, whether they work for private businesses or government agencies. Pharmacists who believe they have been illegally required to dispense these drugs or punished for refusing could sue in federal court for injunctive relief. The bill contains no specific funding or implementation timeline beyond establishing these protections immediately upon enactment.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.